Serious muscle damage from Statins was rare: 4.3 cases per 100,000 years of use in this study. Researchers reviewed regional health records from 2020–2024. They found 1,003 people taking Statins whose Creatine Kinase (CK) exceeded 10 times the lab’s upper normal limit. This blood marker can rise when muscles are worked hard or damaged. Of those people, 32, or 3.2%, were judged to have statin-related muscle damage. That percentage is not the risk for everyone taking these medicines. It applies only to this group with very high test results. The middle Creatine Kinase (CK) reading was 7,800 units per liter in those 32 cases. It was 3,783 in the other people studied. Stronger statin treatment was also more common in the muscle-damage group: 72% versus 52%. These records show a link, not proof that stronger treatment caused the damage. The study also found gaps in testing and recordkeeping. Only 56% of the muscle-damage cases had a specific antibody test. This checks for signs that the immune system is attacking muscle. Only 59% had their statin intolerance recorded in the record’s drug-reaction field. For BioSocial members, the takeaway is about context, not just a high number. A single result cannot show why it rose. Keeping bloodwork dates beside medicine details and recent hard workouts can make comparisons clearer. Workout timing matters because hard exercise can raise this marker too. Sharing that context helps the community compare experiences without assuming every rise has the same cause. What patterns have you noticed in your Creatine Kinase (CK) results alongside medicine use or workout timing?